S. 4069: AI-Ready Bio-Data Standards Act

The AI-Ready Bio-Data Standards Act is aimed at ensuring biological datasets created through federally funded research are suitable for use in artificial intelligence (AI) applications. The bill requires the Director of the National Institute of Standards and Technology (NIST) to establish definitions, standards, resources, and frameworks within two years of enactment for these datasets to be "artificial intelligence-ready." Below are key provisions of the bill:

Definitions and Standards

The bill mandates that NIST must:

• Define what "artificial intelligence-ready" means, ensuring datasets are formatted for effective AI training and support advancements in AI and biotechnology.
• Establish standards to ensure biological datasets meet the definition of being artificial intelligence-ready.

Resources and Frameworks

NIST is required to create the following:

• Data management resources and cybersecurity frameworks for federal agencies involved in funding biological research and for researchers generating datasets.
• Guidelines for making sure those definitions and standards do not impose excessive burdens on researchers receiving federal funds.

Consultation and Public Input

The Director must consult with various stakeholders including:

• Private sector entities from both the biotechnology and artificial intelligence industries.
• Academics and federal agency heads.
• Public feedback will also be solicited to inform the establishment and updates of the definitions and standards.

Annual Review and Updates

The definitions and standards will be reviewed annually, ensuring they remain relevant and effective. Additionally, NIST will conduct evaluations to ensure compliance with the standards and to minimize any undue burden on researchers.

Information Gathering

Within one year, NIST must inventory existing biotechnology standards and datasets that relate to federally funded biological research. This information will then be made publicly accessible through NIST’s website.

Testing and Evaluation

NIST, in collaboration with the National Science Foundation, must conduct tests to evaluate the effectiveness and clarity of the established standards, ensuring they are easy to follow and applicable.

Agency-Specific Data Management Policies

Within two years, NIST must create or revise agency-specific policies that mandate compliance with the established definitions, standards, resources, and frameworks for AI-ready datasets. This includes creating oversight mechanisms and reporting requirements for agencies to ensure adherence to these policies.

Advisory Group

An advisory group will be set up to provide recommendations and review practices for ensuring datasets meet the standards. The group will consist of representatives from federal agencies, academia, and the private sector.

Annual Reports and Sunset Clause

NIST is required to submit annual reports to Congress regarding the establishment and implementation of the definitions, standards, and frameworks. The provisions of this act will terminate ten years after its enactment.

Definitions

The bill includes clear definitions for terms such as "biological data," "biological dataset," and "negative data" to guide its implementation.

Relevant Companies

• ILMN - Illumina, Inc. - A key player in biotechnology that could be significantly impacted due to its focus on genomic data and biological datasets.
• AMGN - Amgen Inc. - A biopharmaceutical company that may need to adapt its data management practices to comply with the new standards for federally funded research data.
• GILD - Gilead Sciences, Inc. - Another major player in biopharmaceuticals that likely deals with biological datasets from federally funded research, potentially subject to new regulations.